Consulting firm says CMS could do more to help regulators . . .

Avalere: 2016 Plans Improve Access To Drugs Treating Complex Diseases

By Donna Haseley / April 19, 2016 at 4:30 PM
A new analysis by consulting firm Avalere finds exchange plans in 2016 provide patients more access to drugs used to treat complex diseases, like HIV, cancer and multiple sclerosis, than they did in prior years. Avalere touts the news as good for consumers, but says CMS could still do more to discourage plans from putting all drugs in a class on the highest cost-sharing tier. The analysis looked at silver-level exchange plans across 20 classes of drugs, and focused on...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.